On February 9, WHX Dubai 2026 commenced. ChoiceMMed made its appearance at booth N25.E55 in the Dubai Exhibition Centre, showcasing its innovative technologies and professional solutions to medical professionals and partners from around the globe. The company presented its leading product portfolio in the fields of blood oxygen detection, respiratory health,and cardiovascular monitoring, once again demonstrating its commitment to advancing global healthcare management.

As one of the most influential medical exhibitions in the Middle East and globally, WHX Dubai attracted thousands of exhibitors and over a hundred thousand professional visitors from across the world. Covering the entire medical industry chain, including medical devices, smart healthcare, and rehabilitation care, the exhibition provided an exceptional platform for global enterprises to connect with the rapidly growing Middle Eastern market. 

The Middle East and surrounding regions show an increasing demand for high-quality, intelligent medical devices suitable for home use. Based on a deep understanding of market needs, ChoiceMMed highlighted several core solutions across its three major product lines: blood oxygen, respiratory health, and cardiovascular monitoring. 

In the field of respiratory health, the ChoiceMMed oxygen concentrator, with its low-noise operation below 42 decibels, offers a quiet oxygen therapy option for patients with chronic respiratory conditions such as COPD. The blood oxygen product line displayed a variety of devices, from fingertip to desktop models. Among these, the variable light intensity technology ensures accurate detection for people of different skin tones, while the dedicated pediatric pulse oximeter reflects the company’s attention to user-specific needs. In cardiovascular health, the card ECG monitor attracted widespread attention for its convenient 30-second rapid detection and atrial fibrillation analysis capabilities. Together, these products form a closed-loop ecosystem covering home monitoring, data connectivity, and professional support. 

At the exhibition, ChoiceMMed’s booth drew continuous crowds, with representatives from medical institutions, distributors, and clinical experts from countries such as Saudi Arabia, the UAE, and Egypt stopping to experience the products. A procurement manager from a local hospital in Dubai commented, "ChoiceMMed’s products effectively combine portability, intelligence, and clinical-grade accuracy, making them particularly suitable for our initiatives promoting home care and remote patient management." Such direct feedback from the market validates the foresight and practicality of ChoiceMMed’s product design and technological approach. 

Supported by TianJin Chasesun Pharmaceutical Co., Ltd., ChoiceMMed continues to strengthen its product development and service network. This participation was not only a showcase of products and technologies but also a proactive response to global health needs. Against the backdrop of the digital health wave, ChoiceMMed will continue to drive innovation, offering smarter, more convenient, and reliable health management solutions to medical institutions and families worldwide.